Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Lee Schwartzberg MD, FACP
Lee S. Schwartzberg MD, FACP Advisory Board
Eric Jonasch MD
Eric Jonasch MD Advisory Board
Barbara Burtness MD
Barbara Burtness MD Advisory Board
See All Experts
featured
Published in Oncology

Expert Opinion / Interview · June 07, 2018

ASCO 2018: Does KEYNOTE 061 Provide a Rationale for Using PD-L1 Inhibitors in First-Line Gastroesophageal Cancer?

Daniel Catenacci MD
Elizabeth Smyth MD
Interview with
Elizabeth Smyth MD

 

 Save  Recommend
 Share

Further Reading

Most Watched This Week

Related Videos